India’s Artificial Joint Exports Surge 50-Fold in a Decade, Signalling Growth in Medical Manufacturing
India is gradually strengthening its position in the global medical technology industry, and the artificial joint segment offers an encouraging example of this transformation. According to trade figures highlighted in recent reports, India’s artificial joint exports have increased more than 50-fold over a decade, rising from approximately US$1.9 million in 2014 to US$95.6 million in 2024.
The development reflects the growing capabilities of Indian medical-device manufacturers and their expanding presence in international markets. More importantly, it demonstrates that India’s manufacturing ambitions are gradually extending beyond traditional sectors such as pharmaceuticals, textiles and automotive components into technologically demanding areas of healthcare.
However, the export boom also reveals an important challenge. India continues to import considerably more artificial joints than it exports, indicating that the country still has considerable ground to cover before becoming self-reliant in advanced orthopaedic implants.
India’s Artificial Joint Exports Record Exceptional Growth
The expansion in artificial joint exports represents a significant change in India’s medical-device manufacturing landscape.
In 2014, India’s artificial joint exports were valued at approximately US$1.9 million. By 2024, the figure had reached US$95.6 million, representing an increase of more than 50 times in export value.
According to World Bank World Integrated Trade Solution (WITS) data based on UN Comtrade, India’s artificial joint exports stood at US$95.63 million in 2024, with shipments weighing approximately 96,715 kilograms.
This growth is particularly noteworthy because artificial joints are specialised medical products that require precision engineering, advanced materials, stringent quality control and extensive clinical validation.
Unlike conventional consumer goods, orthopaedic implants must function safely inside the human body for many years. Their manufacturing therefore demands sophisticated production capabilities and consistent quality standards.
The export performance suggests that Indian manufacturers are increasingly capable of competing in this specialised international market.
United States and Europe Emerge as Important Markets
India’s artificial joint exports are reaching several established international healthcare markets.
The United States was India’s largest destination in 2024, importing artificial joints worth approximately US$28.69 million.
Russia ranked second, with imports valued at US$17.53 million. Lithuania followed with US$9.95 million, while Germany accounted for approximately US$9.26 million. Türkiye imported Indian artificial joints worth approximately US$4.48 million.
The presence of the United States and Germany among the leading destinations is particularly significant. These markets have established medical-device industries and demanding healthcare procurement environments.
Indian manufacturers’ growing presence in these markets indicates an opportunity to build international distribution networks and establish credibility in specialised medical manufacturing.
The geographical distribution also suggests that Indian companies are developing a diversified export market rather than depending exclusively on neighbouring countries or developing economies.
What Is Driving India’s Medical Manufacturing Growth?
Several developments are contributing to India’s expanding medical-device manufacturing ecosystem.
The first is the broader transformation of Indian manufacturing under initiatives such as Make in India. The government has increasingly recognised medical technology as an important sector for industrial development, healthcare security and export growth.
The Production Linked Incentive (PLI) scheme for medical devices, introduced in 2020, is one of the important policy initiatives supporting this transition.
The programme seeks to encourage domestic manufacturing, attract investments and reduce dependence on imported medical equipment. Its targeted segments include implants, medical imaging equipment, radiotherapy devices and anaesthesia and critical-care equipment.
The government has also introduced initiatives to develop medical-device parks. These facilities are intended to provide manufacturers with common testing laboratories, infrastructure and other shared facilities, helping reduce production costs.
Research and development are equally important. Indian manufacturers need to develop indigenous technologies, improve production processes and invest in advanced materials to compete with established international manufacturers.
India’s Medical Device Industry Is Expanding Beyond Traditional Products
The artificial joint export story is part of a larger expansion in India’s medical-device industry.
According to government figures, India’s total medical-device exports increased from approximately ₹20,426 crore in FY2014-15 to ₹42,360 crore in FY2024-25.
This represents more than a doubling of export value over the decade.
India is exporting a wide range of medical products, including surgical instruments, diagnostic equipment, consumables, implants and medical devices used in critical-care settings.
The implants segment has also recorded encouraging growth. Government data shows that implant exports increased from US$99 million in FY2020-21 to US$350 million in FY2024-25.
This development indicates that Indian manufacturers are gradually moving into higher-value medical products rather than concentrating exclusively on conventional medical consumables.
The expansion of domestic manufacturing capabilities could also create opportunities for engineering companies, material suppliers, research institutions and specialised technology businesses.
The Import Challenge: Why Does India Still Depend on Foreign Implants?
Despite the impressive export growth, India’s artificial joint trade figures reveal a significant structural challenge.
In 2024, India imported artificial joints worth approximately US$218.2 million, substantially higher than its exports of US$95.6 million.
The resulting trade deficit was approximately US$122.6 million.
The United States and Switzerland were among India’s largest suppliers. Imports from the United States alone were valued at approximately US$131.4 million, while Switzerland supplied artificial joints worth around US$51.5 million.
This apparent contradiction deserves attention. If Indian manufacturers can produce artificial joints for international markets, why does the country continue importing substantially larger quantities?
The answer lies in the differences between manufacturing capacity and technological capabilities across product categories.
Artificial joints are not a single standardised product. Hip and knee replacement systems have multiple designs, specialised components and different clinical applications. Complex revision implants and advanced systems require extensive engineering capabilities and clinical validation.
International manufacturers also benefit from decades of clinical experience, established relationships with surgeons, regulatory approvals and extensive distribution networks.
Indian manufacturers must strengthen these capabilities if they want to capture a larger share of domestic demand.
The objective should not simply be to replace imported products with locally manufactured alternatives. Domestic products must demonstrate comparable safety, durability and clinical effectiveness.
Government Initiatives Can Accelerate Domestic Manufacturing
The government has an important role in addressing these challenges.
The PLI scheme for medical devices is intended to encourage investment in domestic manufacturing and reduce import dependence.
Medical-device parks in Uttar Pradesh, Madhya Pradesh and Tamil Nadu are also expected to improve the manufacturing ecosystem by providing shared infrastructure and testing facilities.
Another important priority is research and innovation. India needs stronger collaboration between manufacturers, medical institutions, engineering universities and research organisations.
Developing indigenous expertise in titanium alloys, medical-grade polymers, ceramics and advanced surface treatments could improve the competitiveness of Indian orthopaedic implants.
International certifications and clinical studies will also be essential for Indian manufacturers seeking to expand into highly regulated markets.
The Next Opportunity: Becoming a Global Orthopaedic Manufacturing Hub
India’s growing artificial joint exports offer an opportunity to build a much larger medical technology industry.
The country has an established pharmaceutical manufacturing base, a large engineering workforce and a growing network of hospitals and medical institutions.
These advantages could help Indian companies expand into specialised medical products, including orthopaedic implants, cardiac devices, surgical equipment and advanced diagnostic technologies.
However, long-term success will depend on sustained investment in research, manufacturing quality, regulatory compliance and product innovation.
The next stage of growth should focus on increasing exports while simultaneously reducing dependence on imported medical devices.
Conclusion
India’s artificial joint exports increasing from approximately US$1.9 million in 2014 to US$95.6 million in 2024 represents an encouraging development for domestic medical manufacturing.
The growing presence of Indian products in markets such as the United States, Russia and Germany suggests that domestic manufacturers are gradually establishing international competitiveness.
Nevertheless, the country’s artificial joint imports remain considerably higher than exports. Closing this gap will require greater technological investment, stronger domestic research capabilities and wider acceptance of Indian implants among healthcare professionals.
India has demonstrated that it can manufacture sophisticated medical products for international markets. The next challenge is to build an industry capable of meeting a much larger proportion of its own healthcare requirements while becoming a trusted global supplier.
The real measure of success will be India’s ability to combine export growth, technological innovation and domestic manufacturing self-reliance.
You May Also Like :
Comments are closed.